Search

Author/Creator Jeka, S.

1. AB0093 Efficacy of Radiation Synovectomy (Radiosynovectomy or Radiosynoviorthesis) with Yttrium-90 (Y-90) in Exudative Inflammation of Synovial Membrane of Knee Joints in Patients with Rheumatic Diseases. (9th June 2015)

Authors:
Zalewska, J.; Dankiewicz-Fares, I.; Wojciechowski, R.; Jeka, S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
921
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. AB0494 Early Clinical Experiences with Belimumab in Polish Patients with Systemic Lupus Erythematosus. (10th June 2014)

Authors:
Majdan, M.; Kucharz, E.J.; Jeka, S.; Sierakowski, S.; Leszczyński, P.; Tł ustochowicz, W.; Olesińska, M.; Gł uszko, P.; Krężelok, M.; Suszek, D.; Kopeć-Mędrek, M.; Kolossa, K.; Domysławska, I.; Pawlak-Buś, K.; Kur-Zalewska, J.; Felis-Giemza, A.; Zielińska, A.; Brużewicz, S.; Skoczylas, K.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
970
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. AB0854 Effect of tumour necrosis factor alpha inhibitor on serum level of DICKKOPF-1 protein and bone morphogenetic proteins in patients with active ankylosing spondylitis. (23rd January 2014)

Authors:
Korkosz, M.; Gasowski, J.; Leszczynski, P.; Pawlak-Bus, K.; Jeka, S.; Zalewska, J.; Kwasny-Krochin, B.; Grodzicki, T.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
687
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. FRI0053 Analysis of associations between tumor necrosis factor-alpha (TNFA -308 g>a, tnfa -238 g>a, tnfa -857 c>t) and tnf receptors (TNFRA 36 a>g, tnfrb 676 t>g) gene polymorphisms status and responsiveness to tnf-a blockers in rheumatoid arthritis. (23rd January 2014)

Authors:
Swierkot, J.; Bogunia-Kubik, K.; Nowak, B.; Białowąs, K.; Korman, L.; Gębura, K.; Kolossa, K.; Jeka, S.; Wiland, P.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. FRI0140 IMPACT OF BASELINE DEMOGRAPHICS AND DISEASE ACTIVITY ON OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB. (2nd June 2020)

Authors:
Weinblatt, M.; Mysler, E.; Ostor, A.; Broadwell, A.; Jeka, S.; Dunlap, K.; Suboticki, J.; Enejosa, J.; Hendrickson, B.; Zhong, S.; Cherny, K.; Wright, G.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
653
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. LB0001 EFFICACY AND SAFETY OF UPADACITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PsA-1): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL. (13th June 2020)

Authors:
Mcinnes, I.; Anderson, J.; Magrey, M.; Merola, J. F.; Liu, Y.; Kishimoto, M.; Jeka, S.; Pacheco Tena, C. F.; Wang, X.; Chen, L.; Zueger, P.; Pangan, A.; Behrens, F.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Long‐Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate‐to‐ Severe Systemic Lupus Erythematosus: Results From an Open‐Label Extension Study. Issue 4 (24th March 2016)

Authors:
Wallace, D. J.; Hobbs, K.; Clowse, M. E. B.; Petri, M.; Strand, V.; Pike, M.; Merrill, J. T.; Leszczyński, P.; Neuwelt, C. M.; Jeka, S.; Houssiau, F.; Keiserman, M.; Ordi‐Ros, J.; Bongardt, S.; Kilgallen, B.; Galateanu, C.; Kalunian, K.; Furie, R.; Gordon, C.
Journal:
Arthritis care & research
Issue:
Volume 68:Issue 4(2016:Apr.)
Page Start:
534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. OP0053 SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL. (2nd June 2020)

Authors:
Baraliakos, X.; Gossec, L.; Pournara, E.; Jeka, S.; Blanco, R.; D'angelo, S.; Schett, G.; Schulz, B.; Rissler, M.; Nagar, K.; Perella, C.; Coates, L. C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗